Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MIVI-TRUST (TG-MV-007)
NCT00798317Phase 3Completed
- Sponsor
- Oxurion
- Start
- Dec 2008
- Primary completion
- Jun 2010
- Modality
- Therapeutic Enzymes
- Countries
- 7
01
Overview
A Phase 3 trial of ocriplasmin in vitreomacular adhesion (VMA), sponsored by Oxurion. Started Dec 2008; status: completed.
02
Drugs
ocriplasmin
03
Conditions
vitreomacular adhesion (VMA)
Beyond the preview
Go deeper on NCT00798317.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00798317.